This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
30


nanotimes


Companies Facts


N


etronome announced an extension of its stra- tegic relationship with Intel Corp. in which


Netronome’s next generation flow processors will be manufactured on Intel’s leading 22nm process. Netronome is a leading supplier of highly program- mable semiconductor products that are used for in- telligent flow processing in network and communica- tions devices. Netronome’s solutions include tightly integrated network flow processors and acceleration cards that scale to more than 20 Gbps.


http://www.netronome.com N


ovaled AG has filed a registration statement on Form F-1 with the US Securities and Exchange


Commission for a proposed Initial Public Offering (IPO) of its American Depositary Shares (ADSs). Novaled is a leader in the research, development and commercialization of technologies and materials that enhance the performance of organic light-emit- ting diodes, or OLEDs, and other organic electronics.


Novaled intends to apply to have its ADSs listed on the NASDAQ Global Market or New York Stock Exchange. Goldman, Sachs & Co. and Deutsche Bank Securities are acting as joint book-running managers for the offering. Canaccord Genuity, Com- merzbank, Cowen and Company and JMP Securities are acting as co-managers. A registration statement relating to these securities has been filed with the US Securities and Exchange Commission but has not yet become effective.


At their March 28, 2012 annual meeting, the share- holders of Novaled AG also elected Dr. Wolfgang Ziebart as Chairman of Novaled’s Supervisory


Board. Ziebart succeeds Thilo von Selchow, who had completed his term as Chairman of the Supervisory Board. In addition, Ernest E. Maddock was elected as a new member of Novaled’s Supervisory Board and appointed as Head of the Supervisory Board’s Audit Committee. Dr. Jan Blochwitz-Nimoth, co- founder of Novaled, resigned from the Supervisory Board but will continue to serve as Novaled’s Chief Scientific Officer.


Gildas Sorin, CEO of Novaled, said: “We are de- lighted that Dr. Wolfgang Ziebart and Ernest Mad- dock will join Novaled’s Supervisory Board at a time when we are taking the next steps forward for Novaled. Ziebart’s long-standing experience in managing publicly traded companies and Maddock’s extensive industry experience will help us to further develop Novaled’s business. We would also like to thank Thilo von Selchow for his commitment and consistently successful work in supporting Novaled’s development.”


Novaled was founded in 2001 as a spin-off of the Technical University and the Fraunhofer Institute of Dresden. Novaled is headquartered in Dresden with sales offices in Korea and Japan. The Company is a leader in the research, development and com- mercialization of technologies and materials that enhance the performance of Organic Light-Emitting Diodes) and other organic electronics.


http://www.novaled.com P


olypore International, Inc. (NYSE: PPO) reported its financial results for the fourth quarter and year ended December 31, 2011. Sales were $763.1


12-03 :: March/April 2012


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79